SOURCE: Creative Edge Nutrition, Inc.

September 01, 2015 09:00 ET

Creative Edge Nutrition, Inc. Update Letter to Shareholders

BEVERLY HILLS, CA and LAKESHORE, ON--(Marketwired - Sep 1, 2015) - Creative Edge Nutrition, Inc. (OTC PINK: FITX), a nutritional supplement company focusing on active lifestyles, announces an update to its shareholders.

CEN Biotech Inc., a Canadian company in pursuit of licensure under the MMPR program issues the following update; CEN Biotech Inc. has issued and served upon the Office of the Deputy Attorney General of Canada, its Notice of Intent to seek arbitration under Chapter 11 of the NAFTA (North American Free Trade Agreement). This service is being issued since the denial of its application under the MMPR was arbitrary and capricious and not based on any tangible evidence. Chapter 11 of the NAFTA allows investors an avenue for settlement of disputes that ensures equal treatment among all parties.

CEN Biotech Inc. is now in receipt of new factual information evidencing such an arbitrary and capricious denial of its license. Service and notice for arbitration was the appropriate next step to settle the losses its investors have suffered as a result of the MMPR program in Canada. The losses suffered by the company, its investors, and family and friends are immeasurable. Therefore, the company will seek all legal and dispute measures available to raise claim and recapture its losses.

The Notice is seeking an undisclosed, yet sizable amount based on the accumulated potential revenue of its fully completed and inspected medical marijuana manufacturing facility. The Company is seeking losses for the harm, suffering, and general damages pertaining to the inability to commence production of medical marijuana for the Canadian market patients.

CEN Biotech Inc. had applied for 600,000 kgs of medical marijuana annual capacity. Following this application and at the direction of the Canadian MMPR, the Company invested over ten million dollars building a world class production facility. This fully completed and inspected facility resides within one mile of an Ontario Police detachment, was built with Level 9 security protocols, and adheres to Canadian MMPR guidelines.

CEN Biotech Inc. will issue further statements as they become available, but will not answer questions in regards to litigation to ensure natural justice and procedural fairness is had to all parties involved.

About CEN Biotech
CEN Biotech, Inc. was established in 2013 as a partially owned subsidiary of Creative Edge Nutrition (OTC PINK: FITX) for the sole purpose of supplying the Canadian public with pharmaceutical-grade medical cannabis under the newly established Marihuana for Medical Purposes Regulations (MMPR). CEN Biotech Inc. has submitted a comprehensive application to become a licensed producer (LP) of dried marihuana for medicinal purposes and has received a ready-to-build approval from Health Canada. http://www.cenbiotechinc.com info@cenbiotechinc.com

About Creative Edge Nutrition, Inc.
Creative Edge Nutrition, Inc., is a holding company and a Nutritional Supplement Company focused on developing innovative, high quality supplements and energy drinks. The company offers a broad spectrum of capsules, tablets, and powders, as well as science based products in the principal categories of weight management, nutrition challenges, energy and fitness. The Company manufactures under strict GMP guidelines at GMP Certified and/or FDA registered facilities.www.CenergyNutrition.com http://www.drinkgiddyup.com

Company Disclaimer

As a "penny stock" Company, within the meaning of federal and state securities law, Creative Edge Nutrition, Inc. may not avail itself of the Safe Harbor provisions as identified in the Private Securities Litigation Reform Act of 1995. However, Creative Edge Nutrition, Inc. provides the following disclaimer and warning to protect our shareholders, prospective investors and the public at large by alerting them to the risks and uncertainties involved with any investment, and the need to perform their own due diligence and assessment.

This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers.

Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission.

Contact Information